Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis
- 23 December 2004
- journal article
- clinical trial
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 64 (1) , 75-81
- https://doi.org/10.1002/ccd.20238
Abstract
The aim of this study was to assess the effects of percutaneous coronary intervention with drug‐eluting stents (DESs) versus minimally invasive direct coronary artery bypass (MIDCAB) surgery in the management of patients with proximal left anterior descending (LAD) coronary artery stenosis. Until recent years, despite the advantages of percutaneous transluminal coronary angioplasty (PTCA) with bare metal stent implantation, such as shorter hospital stays and recovery time, MIDCAB showed better results with regard to the need for repeated intervention in the target vessel than PTCA with proximal LAD lesions. Symptomatic patients (n = 189) were randomly assigned to DES group (n = 119) and MIDCAB group (n = 70). Patients with an isolated high‐grade lesion (stenosis of ≥ 70% of the luminal diameter) in the proximal LAD coronary artery (from the ostium to the first diagonal branch) were included in this study. During the 6‐month follow‐up period, 1.7% (n = 2) in the DES group needed repeated revascularization procedures for target lesion revascularization compared with 5.9% (n = 4) in the MIDCAB group (P = 0.196). The rates of death and myocardial infarction were similar in both groups [DES 0.0% (n = 0) vs. MIDCAB 2.9% (n = 2), P = 0.135; DES 1.7% (n = 2) vs. MIDCAB 2.9% (n = 2), P = 0.627; respectively] during 6 months of follow‐up. In‐hospital length of stay was significantly shorter in the DES group compared with the MIDCAB group (5.8 ± 2.1 days vs. 8.9 ± 2.6 days; P = 0.001). DES implantation and MIDCAB surgery showed similar rates of myocardial infarction, the need for repeated revascularization, and death during 6 months of follow‐up. However, DES implantation resulted in lower average number of hospital stays and similar postoperative complications. Catheter Cardiovasc Interv 2005;64:75–81.Keywords
This publication has 21 references indexed in Scilit:
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- TAXUS ICirculation, 2003
- Drug-eluting stents in vascular interventionThe Lancet, 2003
- Minimally invasive direct coronary artery bypass (MIDCAB) versus coronary artery stenting for elective revascularization of the left anterior descending arteryThe American Journal of Cardiology, 2002
- Primary stenting versus MIDCAB: preliminary report–Comparision of two methods of revascularization in single left anterior descending coronary artery stenosisThe Annals of Thoracic Surgery, 2002
- Comparison of Stenting with Minimally Invasive Bypass Surgery for Stenosis of the Left Anterior Descending Coronary ArteryNew England Journal of Medicine, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- The revival of surgical treatment for isolated proximal high grade LAD lesions by minimally invasive coronary artery bypass graftingEuropean Journal of Cardio-Thoracic Surgery, 2000
- Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operationThe Annals of Thoracic Surgery, 2000
- Less invasive arterial CABG on a beating heartThe Annals of Thoracic Surgery, 1997